VRCA - Verrica sues to keep unapproved catharidin drugs off US market
2024-02-05 10:53:46 ET
More on Verrica Pharmaceuticals
- Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Call Transcript
- Verrica Pharmaceuticals stock gains on Walgreens distribution deal
- Verrica stock rallies 55% amid positive Phase 3 results for skin drug
- Seeking Alpha’s Quant Rating on Verrica Pharmaceuticals
- Historical earnings data for Verrica Pharmaceuticals